---
title: "Enzyme Replacement Therapy Medicines"
ocid: "ocds-h6vhtk-047918"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-h6vhtk-047918"
markdown_url: "https://d3tenders.com/contract/ocds-h6vhtk-047918.md"
json_url: "https://d3tenders.com/contract/ocds-h6vhtk-047918.json"
source: "Find A Tender Service"
current_stage: "Award"
buyer: "THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (\"NSS\")"
published: "2024-08-15"
---

# Enzyme Replacement Therapy Medicines

Buyer: THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("NSS")  
Current stage: Award  
OCID: ocds-h6vhtk-047918

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-h6vhtk-047918)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-h6vhtk-047918.json)

## Summary

The procurement process for the contract "Enzyme Replacement Therapy Medicines" was conducted by The Common Services Agency, more commonly known as NHS National Services Scotland (NSS). This tender falls under the pharmaceutical products industry category and aims to secure the supply of enzyme replacement therapy medicines including Velaglucerase alfa, Idursulfase, and Agalsidase alfa to NHS Scotland. The procurement was handled through a limited method, awarding a single supplier framework agreement to Takeda UK Limited. Key dates include the contract award announcement on 2nd July 2024 and the framework agreement covering a 24-month duration with a 12-month extension option. The contract is applicable to all entities under the National Health Service (Scotland) Act 1978 and any Integrated Joint Boards established under the new Public Bodies (Joint Working) Scotland Act 2014.

This tender represents a significant opportunity for businesses in the pharmaceutical sector, particularly those specialising in enzyme replacement therapies. The exclusive rights and intellectual property protections governing this framework agreement make it ideal for businesses with the capability to produce these specific medicines. SMEs within this domain may find considerable growth potential through participation, especially given the substantial contract value of over £6 million. The chosen procurement method highlights a streamlined, competitive environment, providing a focused avenue for businesses meeting the specific criteria to engage effectively with NHS Scotland and contribute to public health improvements.

## Notice

Supply of Enzyme Replacement Therapy Medicines (e-g) to NHS Scotland: - NP92624(e) Velaglucerase alfa 400units powder for solution for infusion vials 1 vial (VPRIV(r)) - NP92624(f) Idursulfase 6mg/3ml solution for infusion vials 1 vial (Elaprase(r)) - NP92624(g) Agalsidase alfa 3.5mg/3.5ml solution for infusion vials 1 vial (Replagal(r))

### Lot Information

Lot 1

The Framework Agreement is for the supply of Enzyme Replacement Therapy Medicines (e-g: VPRIV(r)/ Elaprase(r)/ Replagal(r)) to NHS Scotland. The Authority has awarded this framework as a Single supplier framework agreement to one (1) Framework Participant.

### Procurement Information

The medicine to be awarded to the framework agreement is protected by exclusive rights, including intellectual property rights, in line with Regulation 33(1)(b)(iii) of the Public Contracts (Scotland) Regulations 2015.

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Find A Tender Service |
| Latest notice | https://www.find-tender.service.gov.uk/Notice/025941-2024 |
| Notice type | Award Notice |
| Procurement type | Framework |
| Procurement category | Goods |
| Procurement method | Limited |
| Procurement method details | Award procedure without prior publication of a call for competition |
| Tender suitability | Not specified |
| Awardee scale | SME |
| All stages | Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 15 Aug 2024 |
| Submission deadline | Not specified |
| Future notice date | Not specified |
| Award date | 1 Jul 2024 |
| Contract period | Not specified |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | Not specified |
| Lots value | Not specified |
| Awards value | Not specified |
| Contracts value | £12,159,191 |

## Status

| Field | Value |
| --- | --- |
| Tender status | Complete |
| Lots status | Cancelled |
| Awards status | Active |
| Contracts status | Active |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("NSS") |
| Additional buyers | THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (NSS) |
| Locality | EDINBURGH |
| Post town | Edinburgh |
| Postcode | EH12 9EB |
| Country | Scotland |
| ITL 1 | TLM Scotland |
| ITL 2 | TLM1 East Central Scotland |
| ITL 3 | TLM13 City of Edinburgh |
| Local authority | City of Edinburgh |
| Electoral ward | Drum Brae/Gyle |
| Westminster constituency | Edinburgh South West |
| Delivery location | TLM Scotland |

## Supplier

| Field | Value |
| --- | --- |
| Number of suppliers | 1 |
| Supplier names | TAKEDA |

## CPV Codes

### Divisions

- 33 - Medical equipments, pharmaceuticals and personal care products

### Codes

- 33600000 - Pharmaceutical products

## Release History

- 15 Aug 2024 at 10:45 - Award - Award Notice - https://www.find-tender.service.gov.uk/Notice/025941-2024
- 2 Jul 2024 at 12:22 - Award - Award Notice - https://www.find-tender.service.gov.uk/Notice/020106-2024

## Notice URLs

- http://www.nss.nhs.scot/browse/procurement-and-logistics
- https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000774980
- https://www.publiccontractsscotland.gov.uk/search/Search_AuthProfile.aspx?ID=AA11883

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-h6vhtk-047918. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-h6vhtk-047918.json.